Antinuclear antibodies in scleroderma, mixed connective tissue disease and "primary" Raynaud's phenomenon

Clinical Rheumatology

Volumn 7, Issue 1, 1988, Pages 80-86

  Cruz, M ^a   Mejia, G ^a   Lavalle, C ^a   Cortes, J J ^a   Reyes, P A ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Antinuclear Antibodies; MCTD; Raynaud's Phenomenon; Systemic Sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ADULT; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; RAYNAUD PHENOMENON; SCLERODERMA;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; CENTROMERE; DNA; HUMAN; MIDDLE AGE; MIXED CONNECTIVE TISSUE DISEASE; NUCLEAR PROTEINS; NUCLEOPROTEINS; RAYNAUD'S DISEASE; SCLERODERMA, SYSTEMIC;

EID: 0024150829     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/BF02284061     Document Type: Article

References (30)

1. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)
2. Mixed connective tissue disease: A subsequent evaluation of the original 25 patients
3. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease
4. Diversity of antinuclear antibodies in progressive systemic sclerosis
5. Antinuclear antibodies in scleroderma
6. Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma
7. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders
8. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
9. Multiple telangiectasia, Raynaud's phenomenon, sclerodactily, and subcutaneous calcinosis: a syndrome mimicking hereditary telangiectasia
10. CREST Syndrome: a benign variant of scleroderma
11. A prospective study of Raynaud's phenomenon and early connective tissue disease
12. Hemaglutination test for detection of antibodies to deoxyribonucleic acid and nucleoprotein
13. Profiles of antinuclear antibodies in systemic rheumatic diseases
14. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus
15. Studies of cytoplasmic ribonucleoprotein particles from the liver of the rat
16. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis
17. Clinical and laboratory associations of anticentromere antibody in patients with progresive systemic sclerosis
18. The CREST syndrome: a distinct serologic entity with anticentromere antibodies
19. Autoantibody to centromero (kinetochore) in scleroderma sera
20. Anticentromere and anticentriole antibodies in the scleroderma spectrum
21. Anticentromere antibody. Clinical correlations and association with favorable prognosis in patients with scleroderma variants
22. Characterization of centromere (kinetochore) antigen reactive with sera of patients with a scleroderma variant (CREST Syndrome)
23. The anticentromere antibody: disease specificity and clinical significance
24. Antibodies to small nuclear. RNA's complexed with proteins are produced by patients with systemic lupus erythematosus
25. Immune complex nephritis in mixed connective tissue disease
26. Immune-complex glomerulonephritis in a patient with mixed connective tissue disease
27. Immune complex nephropathy in mixed connective tissue disease
28. A histologic evaluation of mixed connective tissue disease in childhood